Coherus Oncology (CHRS) EPS (Basic) (2013 - 2026)
Coherus Oncology (CHRS) posted EPS (Basic) of -$0.01 for Q1 2026, down 113.74% sequentially from $0.07 in Q4 2025, and up 87.11% YoY from -$0.01 in Q1 2025.
Coherus Oncology (CHRS) EPS (Basic) (2013 - 2026) Analysis & Trends
Coherus Oncology has reported EPS (Basic) for 14 years, with the latest figure at -$0.01 in Q1 2026.
- Quarterly EPS (Basic) rose 87.11% year-over-year to -$0.01 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.63 (up 369.01% YoY) and the FY2025 annual result came in at $3.0, up 40.79% from the prior year.
- EPS (Basic) eased to -$0.01 in Q1 2026 per CHRS's latest filing, from $0.07 in the prior quarter.
- Over five years, EPS (Basic) peaked at $2.95 in Q2 2025 and troughed at -$1.24 in Q1 2022.
- A 5-year average of -$0.08 and a median of -$0.08 in 2025 frame the typical range for EPS (Basic).
- The sharpest annual moves came in 2022 and 2025: EPS (Basic) tumbled 128.56% in 2022, then soared 708.29% in 2025.
- Over 5 years, EPS (Basic) stood at -$0.76 in 2022, then declined by 11.55% to -$0.85 in 2023, then soared by 95.25% to -$0.04 in 2024, then jumped by 284.91% to $0.07 in 2025, then slumped by 113.74% to -$0.01 in 2026.
- According to Business Quant data, EPS (Basic) over the past three periods registered -$0.01, $0.07, and $0.08 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 7.59 |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 2.12 |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.23 |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -0.06 |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 0.18 |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -0.72 |
| 10 | Coherus Oncology | 203.82 Mn | 98.51 Mn | 10.07 Mn | -0.13 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.08 |
| Mar 31, 2026 | -0.01 |
| Dec 31, 2025 | 0.07 |
| Sep 30, 2025 | 0.08 |
| Jun 30, 2025 | 2.95 |
| Mar 31, 2025 | -0.08 |
| Dec 31, 2024 | -0.04 |
| Sep 30, 2024 | 0.32 |
| Jun 30, 2024 | 0.37 |
| Mar 31, 2024 | 1.52 |
| Dec 31, 2023 | -0.85 |
| Sep 30, 2023 | -0.41 |
| Jun 30, 2023 | -0.49 |
| Mar 31, 2023 | -0.96 |
| Dec 31, 2022 | -0.76 |
| Sep 30, 2022 | -1.11 |
| Jun 30, 2022 | -0.65 |
| Mar 31, 2022 | -1.24 |
| Dec 31, 2021 | -0.61 |
| Sep 30, 2021 | -0.49 |